Deepak Kanojia
North Western University
H-index: 21
Asia-Bangladesh
Top articles of Deepak Kanojia
MYTX-011: a pH-dependent anti-cMET antibody-drug conjugate designed for enhanced payload delivery to cMET expressing tumor cells
Molecular Cancer Therapeutics
2024/4/30
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models
Communications Medicine
2024/2/20
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases
The Journal of clinical investigation
2023/12/15
MYTX-011 is a highly internalized ADC with anti-tumor activity across a spectrum of NSCLC preclinical models with various levels of cMET expression
2023/12/1
Abstract B124: MYTX-011 is a highly internalized ADC with anti-tumor activity across a spectrum of NSCLC preclinical models with various levels of cMET expression
Molecular Cancer Therapeutics
2023/12/1
Targeting BET proteins decreases hyaluronidase-1 in pancreatic cancer
Cells
2023/5/27
Krishan Kumar
H-Index: 21
Deepak Kanojia
H-Index: 15
MYTX-011: A novel cMET-targeting antibody drug conjugate (ADC) engineered to increase on-target uptake in and efficacy against cMET expressing tumors
Cancer Res.
2023/4/4
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
Nature communications
2023/3/22
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition
bioRxiv
2023
Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain …
Neuro-oncology advances
2022/1/1
Repurposing autophagy regulators in brain tumors
2022/7/15
Translocon-associated protein subunit SSR3 determines and predicts susceptibility to paclitaxel in breast cancer and glioblastoma
Clinical Cancer Research
2022/7/15
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer
Cell chemical biology
2022/3/17
Deepak Kanojia
H-Index: 15
Athanassios Vassilopoulos
H-Index: 21
FKBP1A upregulation correlates with poor prognosis and increased metastatic potential of HNSCC
Cell Biology International
2022/3
Crismita Dmello
H-Index: 6
Deepak Kanojia
H-Index: 15
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
Proceedings of the National Academy of Sciences
2022/1/4
The network of cytokines in brain metastases
Cancers
2021/1
Deepak Kanojia
H-Index: 15
Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy
2021/1/1
Landscape of combination therapy trials in breast cancer brain metastasis
2020/10/1
Jawad Fares
H-Index: 19
Deepak Kanojia
H-Index: 15
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Science translational medicine
2020/8/26
Genes that mediate metastasis across the blood–brain barrier
2020/8/1
Jawad Fares
H-Index: 19
Deepak Kanojia
H-Index: 15
Co-Authors
